Article ; Online: Extracellular vesicle-associated small heat shock proteins as therapeutic agents in neurodegenerative diseases and beyond.
Advanced drug delivery reviews
2021 Volume 179, Page(s) 114009
Abstract: Increasing evidence points towards using extracellular vesicles (EVs) as a therapeutic strategy in neurodegenerative diseases such as multiple sclerosis, Parkinson's, and Alzheimer's disease. EVs are nanosized carriers that play an essential role in ... ...
Abstract | Increasing evidence points towards using extracellular vesicles (EVs) as a therapeutic strategy in neurodegenerative diseases such as multiple sclerosis, Parkinson's, and Alzheimer's disease. EVs are nanosized carriers that play an essential role in intercellular communication and cellular homeostasis by transporting an active molecular cargo, including a large variety of proteins. Recent publications demonstrate that small heat shock proteins (HSPBs) exhibit a beneficial role in neurodegenerative diseases. Moreover, it is defined that HSPBs target the autophagy and the apoptosis pathway, playing a prominent role in chaperone activity and cell survival. This review elaborates on the therapeutic potential of EVs and HSPBs, in particular HSPB1 and HSPB8, in neurodegenerative diseases. We conclude that EVs and HSPBs positively influence neuroinflammation, central nervous system (CNS) repair, and protein aggregation in CNS disorders. Moreover, we propose the use of HSPB-loaded EVs as advanced nanocarriers for the future development of neurodegenerative disease therapies. |
---|---|
MeSH term(s) | Apoptosis/drug effects ; Apoptosis/physiology ; Autophagy/drug effects ; Autophagy/physiology ; Central Nervous System Diseases/drug therapy ; Central Nervous System Diseases/physiopathology ; Drug Carriers ; Extracellular Vesicles/metabolism ; Heat-Shock Proteins, Small/pharmacology ; Heat-Shock Proteins, Small/therapeutic use ; Humans ; Inflammation/physiopathology ; Nanoparticle Drug Delivery System/pharmacology ; Nanoparticle Drug Delivery System/therapeutic use ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/physiopathology |
Chemical Substances | Drug Carriers ; Heat-Shock Proteins, Small ; Nanoparticle Drug Delivery System |
Language | English |
Publishing date | 2021-10-18 |
Publishing country | Netherlands |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 639113-8 |
ISSN | 1872-8294 ; 0169-409X |
ISSN (online) | 1872-8294 |
ISSN | 0169-409X |
DOI | 10.1016/j.addr.2021.114009 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2241: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.